MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-03-0041724
Nidedak Pharmaceuticals Private Limited
Nidedak Pharmaceuticals Private Limited - pharma in Allahabad, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹8.51 Lakh
▼ 10% YoY
Net profit · FY 2024
₹8,390
Net margin 1%
EBITDA · FY 2024
₹38,840
EBITDA margin 4.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹3 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Nidedak Pharmaceuticals Private Limited
Data last updated:
Nidedak Pharmaceuticals Private Limited is a private limited company based in Allahabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2018PTC101158. Its GSTIN is 09AAFCN9443E1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Archana Devi and Sanjay Kumar Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lig – 21 Devprayagam Vikas Yojna Jhalwa, Allahabad, Uttar Pradesh, India – 211015.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.51 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹8,390 (net margin 1%) and EBITDA of ₹38,840 (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years.
As per MCA filings, the company has open charges of ₹3 Lakh on record.
Nidedak Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-03-0041724).
Company details
CIN U74999UP2018PTC101158
Registration Number 101158
Incorporation Date 20 February 2018
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-03-0041724
Recognitions & Rankings of Nidedak Pharmaceuticals
Contact details
Nidedak Pharmaceuticals Private Limited's registered office is in Allahabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressLig – 21 Devprayagam Vikas Yojna Jhalwa, Allahabad, Uttar Pradesh, India – 211015
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nidedak Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Nidedak Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nidedak Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nidedak Pharmaceuticals Private Limited, buy the company report.
Financials of Nidedak Pharmaceuticals Private Limited
FY 2025 filings availableNidedak Pharmaceuticals Private Limited reported revenue of ₹8.51 Lakh (down 10% YoY) for FY 2024.
Revenue · FY 2024
₹8.51 Lakh ▼ 10%
Net profit · FY 2024
₹8,390 margin 1%
EBITDA · FY 2024
₹38,840 margin 4.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 129%
3 years · compounded
▼ 11%
5 years · compounded
▲ 39%
Revenue fell 10% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 129% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38,840 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,390 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nidedak Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nidedak Pharmaceuticals Private Limited
Nidedak Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Devi | Director | 20 Feb 2018 | 8 Years 8 Months | Current |
| Sanjay Kumar Tripathi | Director | 20 Feb 2018 | 8 Years 8 Months | Current |
Charges & borrowings
Open charges
₹3 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jun 2023 | 100737583 | Others | ₹3 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Nidedak Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nidedak Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nidedak Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCN9443E1Z9 | Uttar Pradesh | Active | 13 Dec 2019 |
To see the full GST registrations and return filing status of Nidedak Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nidedak Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Archana Devi was appointed as Director on 20 Feb 2018.
AGM
Nidedak Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nidedak Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
A charge with Others amounted to Rs. 3.00 Lakh with Charge ID 100737583 was registered on 09 Jun 2023.
Appointed
Archana Devi was appointed as Director.
Appointed
Sanjay Kumar Tripathi was appointed as Director.
Incorporation
20 Feb 2018
Nidedak Pharmaceuticals Private Limited was registered on 20 Feb 2018 with Roc Uttar Pradesh I & aged 8 years 8 months as per MCA records.
Frequently asked questions
Nidedak Pharmaceuticals is an active private limited company based in Allahabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 February 2018 (8+ years old) and is registered under CIN U74999UP2018PTC101158.
Nidedak Pharmaceuticals has 2 current directors:
- Archana Devi - Director
- Sanjay Kumar Tripathi - Director
The latest financial statements of Nidedak Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Nidedak Pharmaceuticals is 09AAFCN9443E1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nidedak Pharmaceuticals is U74999UP2018PTC101158. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nidedak Pharmaceuticals was incorporated on 20 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Archana Devi was appointed as Director on 20 Feb 2018. Sanjay Kumar Tripathi was appointed as Director on 20 Feb 2018.
Yes, Nidedak Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-03-0041724).
The registered office of Nidedak Pharmaceuticals is at Lig – 21 Devprayagam Vikas Yojna Jhalwa, Allahabad, Uttar Pradesh, India – 211015.
Nidedak Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages